Page 29 - Noble-Virtual-Healthcare-2024

GoHealth, Inc.

SELECTED FINANCIAL ITEMS GOCO

(in millions of USD)
CQ1 '23 CQ2 '23 CQ3 '23 CQ4 '23 LTM
Income Statement Key Items
Total Revenue 183.16 142.78 132.04 276.70 734.67
Gross Profit 137.70 106.36 96.05 235.61 575.71
Gross Margin 75% 74% 73% 85% 78%
EBIT (5.75) (50.33) (37.98) 25.06 (68.99)
EBIT Margin -3% -35% -29% 9% -9%
Net Income to Common Shareholders (22.54) (70.23) (56.20) (2.29) (151.27)
Net Margin -12% -49% -43% -1% -21%

Balance Sheet Key Items
Total Assets 1,543.45 1,482.25 1,437.41 1,499.57 1,499.57
Cash & Short Term Investments 32.33 25.36 26.39 90.81 90.81
% of Assets 2% 2% 2% 6% 6%
Current Assets -Total 375.46 368.10 346.32 476.44 476.44
% of Assets 24% 25% 24% 32% 32%
Total Liabilities 970.85 972.19 983.49 1,044.62 1,044.62
% of Assets 63% 66% 68% 70% 70%
Current Liabilities - Total 209.81 210.26 217.78 370.01 370.01
% of Assets 14% 14% 15% 25% 25%
Long Term Debt 490.21 496.22 496.97 422.71 422.71
% of Assets 32% 33% 35% 28% 28%
Total Equity 572.60 510.06 453.92 454.96 454.96
% of Assets 37% 34% 32% 30% 30%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities 20.48 10.86 6.50 71.30 109.14
Net Cash Flow - Investing (2.23) (2.43) (3.43) (5.65) (13.73)
Net Cash Flow - Financing (2.40) (15.43) (2.19) (1.09) (21.11)

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Nineteenth Annual Small & Microcap Investor Conference